The delisting risk is materially reduced but not eliminated — monitor for Nasdaq's formal confirmation letter and the next periodic report for ongoing compliance. The IP license provides a strategic product pathway but with no near-term revenue visibility; watch for any revenue-sharing disclosures in the upcoming 10-Q.
Price Chart
Executive Summary
DataMeds AI entered into an IP license agreement with REBOOT Health AI, issuing 666,667 shares valued at $2,000,000 for an exclusive license to use REBOOT's AI platform in its GLP-1 weight management business. Separately, the company reports that it has remediated its Nasdaq minimum stockholders' equity deficiency through a series of transactions including vendor conversions, an acquisition, debt extinguishment, and this equity issuance, and now believes it has over $2,500,000 in stockholders' equity, though formal Nasdaq confirmation is pending. The filing combines a strategic license deal with a critical delisting risk update, making the overall picture mixed.
Key Financial Metrics
Key Facts
- DataMeds entered an exclusive IP license agreement with REBOOT Health AI for use of its AI platform in the GLP-1 weight management B2C business.
- DataMeds issued 666,667 shares of common stock to REBOOT, valued at $2,000,000, as license consideration.
- If the market value of those shares is less than $2,000,000 after 180 days, DataMeds must issue additional shares to cover the shortfall.
- DataMeds also paid $50,000 toward platform reconfiguration costs, estimated at a minimum of $100,000 total.
- REBOOT will receive a portion of DataMeds' Adjusted Gross Revenue from use of the technology.
- DataMeds had a stockholders' equity deficiency of $(12,447,801) as of Dec 31, 2025, triggering a Nasdaq deficiency letter.
- Since the deficiency letter, DataMeds converted ~$1.5M of vendor payables into stock, issued 636,328 shares for Helomics acquisition, extinguished ~$18.7M of debt, and issued the 666,667 shares to REBOOT.
- DataMeds believes it now has over $2,500,000 in stockholders' equity and awaits Nasdaq's formal confirmation.
- Nasdaq will continue to monitor compliance; failure at the next periodic report could trigger delisting proceedings.
- The 666,667 shares were issued in a private placement exempt from registration under Section 4(a)(2) and/or Regulation D.
Financial Impact
Equity issuance of 666,667 shares valued at $2,000,000; debt extinguishment of ~$18.7M; vendor conversions of ~$1.5M; $50,000 cash payment for platform reconfiguration.
Risk Factors
- Nasdaq may not formally confirm compliance, or the company may fail the equity test at the next periodic report, leading to delisting.
- The IP license generates no immediate revenue and involves ongoing revenue sharing, diluting future economics.
- Potential additional dilution if the 180-day market value of the issued shares falls below $2,000,000.
- The company has a history of negative stockholders' equity and reliance on equity/debt restructuring to maintain listing.
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-047451 |
| Document: 0001493152-26-047451-index-headers.html | 0001493152-26-047451 |
| Document: 0001493152-26-047451-index.html | 0001493152-26-047451 |
| Document: 0001493152-26-047451.txt | 0001493152-26-047451 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $2.15 | awaiting T+20 | — | $2.19 (−1.86%) |
Oct 20, 2026 6d ago | 8-K | $2.75 | awaiting T+20 | — | $2.19 (−20.36%) |
Oct 16, 2026 10d ago | 8-K | $2.67 | awaiting T+20 | — | $2.19 (−17.98%) |
Oct 13, 2026 13d ago | 8-K | $2.85 | awaiting T+20 | — | $2.19 (−23.16%) |
Sep 17, 2026 5w ago | 8-K | $3.76 $2.63 | ▼ −30.05% | ▼ −30.26% | $2.19 (−41.76%) |
Sep 16, 2026 5w ago | 8-K | $4.64 $2.85 | ▼ −38.58% | ▼ −39.78% | $2.19 (−52.80%) |
Aug 18, 2026 9w ago | 8-K | $1.38 $6.07 | ▼ −339.86% | ▼ −341.60% | $2.19 (−58.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers